If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website. Thanks in advance for your time.
Skip to content. Search for books, journals or webpages All Pages Books Journals. View on ScienceDirect. Editors: Lee Eiden. Paperback ISBN: Novel systemically active galanin receptor 2 ligands in depression-like behavior.
Recommended for you
A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Endocannabinoid system and mood disorders: Priming a target for new therapies. Antidepressants act directly on astrocytes: Evidences and functional consequences.
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Branched-chain amino acids alter neurobehavioral function in rats. Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists.
The Chlorpromazine Enigma. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.
DCNT Hiroshima University Graduate School
The genetics of selective serotonin reuptake inhibitors. Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials LDAEP in major depressive disorder. Effect of dialkyl- [2- 1-oxa-3,4,9-triaza-fluorenyl-methoxy ethyl] amines on biogenic amines: new potential antidepressants. Synergistic antidepressant-like action of gaboxadol and escitalopram.
Modulatory effects of acupuncture on murine depression-like behavior following chronic systemic inflammation. Involvement of monoaminergic systems in the antidepressant-like effect of Eugenia brasiliensis Lam. Myrtaceae in the tail suspension test in mice. The antidepressant-like action of a simple selenium-containing molecule, methyl phenyl selenide, in mice.
Depression: A neuropsychoanalytic perspective. Fructus Aurantii induced antidepressant effect via its monoaminergic mechanism and prokinetic action in rat. Preclinical discovery of duloxetine for the treatment of depression. Effects of a putative antidepressant with a rapid onset of action in defeated mice with different coping strategies.
Noradrenergic Dysfunction in Depression and Suicide. Key players in major and bipolar depression—A retrospective analysis of in vivo imaging studies. The Origins of Human Modernity. Antidepressants: past, present and future. Taurine and glutathione levels in plasma before and after ECT treatment.
Antioxidants as Antidepressants.
Tobacco addiction and the dysregulation of brain stress systems. Agomelatine: a review for general practitioners. MicroRNAs and depression. Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Antidepressant effects of standardized extract of Centella asiatica L in olfactory bulbectomy model.
Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing.
Frontiers in Catecholamine Function from Synapses to Disease
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: Evidence for the involvement of the serotonergic system. Design of novel quinazolinone derivatives as inhibitors for 5HT 7 receptor. Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Pharmacogenetics of antidepressants and mood stabilizers. Cognitive Mechanisms of Treatment in Depression. Pharmacology and neuroimaging of antidepressant action.
Towards a glutamate hypothesis of depression. Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs? New views on antidepressant action. Development of new radiopharmaceuticals for imaging monoamine oxidase B. Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: Why depression feels so bad and what addicts really want.
The psychological neuroscience of depression: Implications for understanding effects of deep brain stimulation. Noradrenergic System in Depression. Glutamatergic System and Mood Disorders. Chronobiological Rhythms, Melatonergic System, and Depression. The tale of Rauwolfia Serpentina and the contributions of Asian Psychiatry.
Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
Barriers to achieving treatment goals: A focus on sleep disturbance and sexual dysfunction. Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective. Molecular imaging in patients with mood disorders: a review of PET findings.
- Recommended for you.
- Catecholamine Research: From Molecular Insights to Clinical Medicine - Google Books.
- Conference Description!
- Log in to Wiley Online Library!
- From Molecular Insights to Clinical Medicine.
- Classic Jazz: Third Ear - The Essential Listening Companion.
Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones. Functional Neuroimaging in Geriatric Depression. Neurobiology of depression: findings, controversies and perspectives. Antidepressants in counselling psychology: Relevance, effectiveness and implications for practice. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. The role of the central noradrenergic system in behavioral inhibition. Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems.